بررسی پلی مورفیسم ژن FOXP3 در بیماران مبتلا به میگرن

Analysis of FOXP3 polymorphism in migraine in Iranian patients


چاپ صفحه
پژوهان
صفحه نخست سامانه
مجری و همکاران
مجری و همکاران
داوری ها
داوری ها
منابع
منابع
علوم پزشکی اراک
علوم پزشکی اراک

مجریان: فردین فرجی , قاسم مسیبی

اطلاعات کلی طرح
hide/show

کد طرح 3186
عنوان فارسی طرح بررسی پلی مورفیسم ژن FOXP3 در بیماران مبتلا به میگرن
عنوان لاتین طرح Analysis of FOXP3 polymorphism in migraine in Iranian patients
کلمات کلیدی پلی مورفیسم ,FOXP3 ,میگرن
نوع پروژه بنیادی - کاربردی
وضعیت طرح دست اجرا
نوع مطالعاتی مورد شاهدی (Case control)
زمان اجرای طرح -ماه 16
کد IRCT
کد اخلاق IR.ARAKMU.REC.1397.238
نتیجه کمیته اخلاق کد اخلاق دریافت کرد.

اطلاعات مجری و همکاران
hide/show

نام و نام‌خانوادگی سمت در طرح نوع همکاری درجه‌تحصیلی پست الکترونیک
مانا شجاع پورمجری اصلی اول دکتری تخصصی /Ph.Dmana_shojapuor@yahoo.com
فردین فرجیمجریدوم دکتری تخصصی /Ph.Dfardin.faraji@yahoo.com
قاسم مسیبیمجریسوم دکتری تخصصی /Ph.Dgmosayebi@yahoo.com

چکیده طرح
hide/show

عنوان متن
چکیده طرح

داوری ها
hide/show

تاریخ ارسال به داور/بررس مهلت پاسخگویی تاریخ پاسخ داور/بررس نظر داوری/ بررسی توضیحات داور

منابع
hide/show

1. Lipton, R.B.; Bigal, M.E. The epidemiology of migraine. The American journal of medicine 2005, 118 Suppl 1, 3S-10S. 2. Sharma, N.; Mishra, D. International classification of headache disorders, 3rd edition: What the pediatrician needs to know. Indian pediatrics 2014, 51, 123-124. 3. Oterino, A.; Toriello, M.; Valle, N.; Castillo, J.; Alonso-Arranz, A.; Bravo, Y.; Ruiz-Alegria, C.; Quintela, E.; Pascual, J. The relationship between homocysteine and genes of folate-related enzymes in migraine patients. Headache 2010, 50, 99-168. 4. Lea, R.; Colson, N.; Quinlan, S.; Macmillan, J.; Griffiths, L. The effects of vitamin supplementation and mthfr (c677t) genotype on homocysteine-lowering and migraine disability. Pharmacogenetics and genomics 2009, 19, 422-428. 5. Arumugam, M.; Parthasarathy, V. Reduction of cd4+cd25+ regulatory t-cells in migraine: Is migraine an autoimmune disorder? Journal of Neuroimmunology 2016, 290, 54-59. 6. Munno, I.; Centonze, V.; Marinaro, M.; Bassi, A.; Lacedra, G.; Causarano, V.; Nardelli, P.; Cassiano, M.A.; Albano, O. Cytokines and migraine: Increase of il-5 and il-4 plasma levels. Headache 1998, 38, 465-467. 7. Munno, I.; Marinaro, M.; Bassi, A.; Cassiano, M.A.; Causarano, V.; Centonze, V. Immunological aspects in migraine: Increase of il-10 plasma levels during attack. Headache 2001, 41, 764-767. 8. Empl, M.; Sostak, P.; Breckner, M.; Riedel, M.; Müller, N.; Gruber, R.; Förderreuther, S.; Straube, A. T-cell subsets and expression of integrins in peripheral blood of patients with migraine. Cephalalgia 1999, 19, 713-717. 9. Kemper, R.H.A.; Meijler, W.J.; Korf, J.; Ter Horst, G.J. Migraine and function of the immune system: A meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001, 21, 549-557. 10. Dalla Libera, D.; Di Mitri, D.; Bergami, A.; Centonze, D.; Gasperini, C.; Grasso, M.G.; Galgani, S.; Martinelli, V.; Comi, G.; Avolio, C., et al. T regulatory cells are markers of disease activity in multiple sclerosis patients. PloS one 2011, 6, e21386. 11. Kono, K.; Kawaida, H.; Takahashi, A.; Sugai, H.; Mimura, K.; Miyagawa, N.; Omata, H.; Fujii, H. Cd4(+)cd25high regulatory t cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer immunology, immunotherapy : CII 2006, 55, 1064-1071. 12. Watanabe, M.A.; Oda, J.M.; Amarante, M.K.; Cesar Voltarelli, J. Regulatory t cells and breast cancer: Implications for immunopathogenesis. Cancer metastasis reviews 2010, 29, 569-579. 13. Campbell, D.J. Control of regulatory t cell migration, function and homeostasis. Journal of immunology (Baltimore, Md. : 1950) 2015, 195, 2507-2513. 14. de Reuver, P.R.; Mehta, S.; Gill, P.; Andrici, J.; D'Urso, L.; Clarkson, A.; Mittal, A.; Hugh, T.J.; Samra, J.S.; Gill, A.J. Immunoregulatory forkhead box protein p3-positive lymphocytes are associated with overall survival in patients with pancreatic neuroendocrine tumors. Journal of the American College of Surgeons 2016, 222, 281-287. 15. Bennett, C.L.; Brunkow, M.E.; Ramsdell, F.; O'Briant, K.C.; Zhu, Q.; Fuleihan, R.L.; Shigeoka, A.O.; Ochs, H.D.; Chance, P.F. A rare polyadenylation signal mutation of the foxp3 gene (aauaaa-->aaugaa) leads to the ipex syndrome. Immunogenetics 2001, 53, 435-439. 16. Bassuny, W.M.; Ihara, K.; Sasaki, Y.; Kuromaru, R.; Kohno, H.; Matsuura, N.; Hara, T. A functional polymorphism in the promoter/enhancer region of the foxp3/scurfin gene associated with type 1 diabetes. Immunogenetics 2003, 55, 149-156. 17. Engela, A.U.; Boer, K.; Roodnat, J.I.; Peeters, A.M.A.; Eilers, P.H.; Kal-van Gestel, J.A.; Rivadeneira, F.; Weimar, W.; Baan, C.C. Genetic variants of foxp3 influence graft survival in kidney transplant patients. Human Immunology 2013, 74, 751-757. 18. Lan, Y.; Tang, X.S.; Qin, J.; Wu, J.; Qin, J.M. [association of transcription factor foxp3 gene polymorphism with genetic susceptibility to systematic lupus erythematosus in guangxi zhuang population]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2010, 27, 433-436. 19. Jahan, P.; Cheruvu, R.; Tippisetty, S.; Komaravalli, P.L.; Valluri, V.; Ishaq, M. Association of foxp3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from india. Journal of the American Academy of Dermatology 2013, 69, 262-266. 20. Ban, Y.; Tozaki, T.; Tobe, T.; Ban, Y.; Jacobson, E.M.; Concepcion, E.S.; Tomer, Y. The regulatory t cell gene foxp3 and genetic susceptibility to thyroid autoimmunity: An association analysis in caucasian and japanese cohorts. Journal of Autoimmunity 2007, 28, 201-207. 21. Hassannia, H.; Abediankenari, S.; Ghaffari, J. Foxp3 and tgf-beta gene polymorphisms in allergic rhinitis. Iranian journal of immunology : IJI 2011, 8, 218-225. 22. Wu, Z.; You, Z.; Zhang, C.; Li, Z.; Su, X.; Zhang, X.; Li, Y. Association between functional polymorphisms of foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a chinese han population. Clinical and Developmental Immunology 2012, 2012, 7. 23. Jafarzadeh, A.; Jamali, M.; Mahdavi, R.; Ebrahimi, H.A.; Hajghani, H.; Khosravimashizi, A.; Nemati, M.; Najafipour, H.; Sheikhi, A.; Mohammadi, M.M., et al. Circulating levels of interleukin-35 in patients with multiple sclerosis: Evaluation of the influences of foxp3 gene polymorphism and treatment program. Journal of molecular neuroscience : MN 2015, 55, 891-897. 24. Chen, Y.; Zhang, H.; Liao, W.; Zhou, J.; He, G.; Xie, X.; Fei, R.; Qin, L.; Wei, L.; Chen, H. Foxp3 gene polymorphism is associated with hepatitis b-related hepatocellular carcinoma in china. Journal of Experimental & Clinical Cancer Research : CR 2013, 32, 39-39. 25. He, Y.Q.; Bo, Q.; Yong, W.; Qiu, Z.X.; Li, Y.L.; Li, W.M. Foxp3 genetic variants and risk of non-small cell lung cancer in the chinese han population. Gene 2013, 531, 422-425. 26. Jahan, P.; Ramachander, V.R.; Maruthi, G.; Nalini, S.; Latha, K.P.; Murthy, T.S. Foxp3 promoter polymorphism (rs3761548) in breast cancer progression: A study from india. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014, 35, 3785-3791. 27. bahadivand chegini, h.; pourgheysari, b.; pourahmadiyan, a.; kazemi, s.; shirzad, H.; mosavi, m.; drees, f. Association between rs56066773 and rs56232250 polymorphisms of foxp3 gene in target site of microrna with rheumatoid arthritis in patients referred to emam ali clinic of shahrekord. Journal of Shahrekord Uuniversity of Medical Sciences 2016, 18, 9-17.